
    
      The COVID-19 disease has been shown to be associated to higher mortality risk and health
      adverse consequences. Despite of the fact that the SAR-COV2 virus has been shown that affects
      every populations, the negative impact is higher in older people, pointing this population as
      the most severely affected.

      The COVID-Age Brugmann study aims to identify if comorbidity, geriatric syndromes, and health
      issues at admission are associated to mortality risk in older patients admitted to an acute
      care unit due to COVID-19
    
  